Illumina Financial Statements From 2010 to 2025

ILMN Stock

USD 132.92 1.56 1.16%

Illumina's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Illumina's valuation are provided below:

Gross Profit

2.9 B

Profit Margin

0.164

Market Capitalization

20.7 B

Enterprise Value Revenue

5.1116

Revenue

4.3 B

We have found one hundred twenty available fundamental trends for Illumina, which can be analyzed and compared to other ratios and to its competitors. Self-guided Investors are advised to confirm Illumina's regular fundamentals against the trend between 2010 and 2025 to make sure the company can sustain itself down the road. As of the 30th of December 2025, Market Cap is likely to grow to about 1.6 B. Also, Enterprise Value is likely to grow to about 1.6 B

Illumina Total Revenue

4.59 Billion

Check Illumina financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Illumina's main balance sheet or income statement drivers, such as Depreciation And Amortization of 371.7 M, Interest Expense of 61.4 M or Total Revenue of 4.6 B, as well as many indicators such as Price To Sales Ratio of 5.19, Dividend Yield of 0.0 or PTB Ratio of 5.46. Illumina financial statements analysis is a perfect complement when working with Illumina Valuation or Volatility modules.

Build AI portfolio with Illumina Stock

Check out the analysis of Illumina Correlation against competitors.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

Illumina Balance Sheet

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Total Assets

4.1 B

6.3 B

5.9 B

Slightly volatile

Short and Long Term Debt Total

2.8 B

2.6 B

1.7 B

Slightly volatile

Other Current Liabilities

224.9 M

387 M

316.2 M

Slightly volatile

Total Current Liabilities

1.6 B

1.5 B

998 M

Slightly volatile

Total Stockholder Equity

2.3 B

2.4 B

3.3 B

Slightly volatile

Property Plant And Equipment Net

1.3 B

1.2 B

891.2 M

Slightly volatile

Accounts Payable

232.1 M

221 M

159.8 M

Slightly volatile

Cash

694.8 M

1.1 B

996.4 M

Slightly volatile

Non Current Assets Total

2.2 B

3.6 B

3.3 B

Slightly volatile

Non Currrent Assets Other

68.9 M

121 M

95.4 M

Slightly volatile

Cash And Short Term Investments

1.2 B

1.7 B

Slightly volatile

Net Receivables

788.5 M

751 M

457.1 M

Slightly volatile

Common Stock Shares Outstanding

130.9 M

159 M

138.2 M

Slightly volatile

Short Term Investments

88.3 M

93 M

690.9 M

Pretty Stable

Liabilities And Stockholders Equity

4.1 B

6.3 B

5.9 B

Slightly volatile

Non Current Liabilities Total

2.5 B

2.4 B

1.7 B

Slightly volatile

Other Current Assets

239.4 M

228 M

127.1 M

Slightly volatile

Total Liabilities

4.1 B

3.9 B

2.7 B

Slightly volatile

Total Current Assets

1.8 B

2.7 B

2.6 B

Slightly volatile

Short Term Debt

606.9 M

578 M

304.6 M

Slightly volatile

Intangible Assets

512 M

295 M

773.8 M

Slightly volatile

Common Stock

1.4 M

2.3 M

1.8 M

Slightly volatile

Other Liabilities

783.7 M

746.4 M

378.4 M

Slightly volatile

Current Deferred Revenue

273 M

260 M

150.5 M

Slightly volatile

Long Term Debt

809 M

1.5 B

1 B

Slightly volatile

Common Stock Total Equity

1.5 M

2.3 M

1.8 M

Slightly volatile

Inventory

574.4 M

547 M

335.1 M

Slightly volatile

Property Plant And Equipment Gross

2.6 B

2.5 B

1.1 B

Slightly volatile

Property Plant Equipment

1.3 B

1.2 B

782.6 M

Slightly volatile

Good Will

1.2 B

1.1 B

1.4 B

Slightly volatile

Net Tangible Assets

4.9 B

4.7 B

2.3 B

Slightly volatile

Capital Surpluse

5 B

7.5 B

4.4 B

Slightly volatile

Non Current Liabilities Other

358.7 M

339 M

319 M

Slightly volatile

Deferred Long Term Asset Charges

83.9 M

101.2 M

86.3 M

Slightly volatile

Warrants

57.6 M

70.2 M

52.4 M

Slightly volatile

Long Term Debt Total

1.2 B

1.5 B

1.1 B

Slightly volatile

Long Term Investments

176 M

313.9 M

168.2 M

Slightly volatile

Short and Long Term Debt

516.4 M

573.9 M

488.9 M

Slightly volatile

Net Invested Capital

7.5 B

4.4 B

5.6 B

Slightly volatile

Net Working Capital

1.7 B

1.2 B

2.1 B

Slightly volatile

Capital Stock

1.6 M

1.8 M

2 M

Slightly volatile

Cash And Equivalents

1.2 B

1.1 B

1.7 B

Slightly volatile

Illumina Income Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Depreciation And Amortization

371.7 M

354 M

195.4 M

Slightly volatile

Total Revenue

4.6 B

4.4 B

2.8 B

Slightly volatile

Gross Profit

3 B

2.9 B

1.9 B

Slightly volatile

Other Operating Expenses

5.5 B

5.2 B

2.6 B

Slightly volatile

Research Development

1.2 B

672.3 M

Slightly volatile

Total Operating Expenses

3.9 B

3.7 B

2 B

Slightly volatile

Selling General Administrative

1.1 B

772.3 M

Slightly volatile

Selling And Marketing Expenses

346.7 M

422.5 M

350 M

Slightly volatile

Tax Provision

37.6 M

39.6 M

125.2 M

Slightly volatile

Interest Income

43.7 M

46 M

87.2 M

Pretty Stable

Reconciled Depreciation

294.4 M

354 M

220.5 M

Slightly volatile

Illumina Cash Flow Statement

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Begin Period Cash Flow

647.5 M

1 B

937.8 M

Slightly volatile

Depreciation

371.7 M

354 M

195.2 M

Slightly volatile

Capital Expenditures

124.4 M

128 M

172.2 M

Slightly volatile

End Period Cash Flow

694.8 M

1.1 B

996.4 M

Slightly volatile

Stock Based Compensation

388.5 M

370 M

232.2 M

Slightly volatile

Issuance Of Capital Stock

64.7 M

56 M

52.8 M

Slightly volatile

Financial Ratios

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Price To Sales Ratio

5.19

5.46

7.7969

Pretty Stable

PTB Ratio

5.46

3.35

7.1543

Slightly volatile

Days Sales Outstanding

88.87

70.08

60.7877

Slightly volatile

Book Value Per Share

34.36

32.72

26.9806

Slightly volatile

Operating Cash Flow Per Share

2.06

2.72

3.4586

Pretty Stable

Average Payables

418.1 K

470.3 K

512.8 K

Slightly volatile

Stock Based Compensation To Revenue

0.0922

0.097

0.0769

Slightly volatile

Capex To Depreciation

0.49

0.52

1.1184

Slightly volatile

PB Ratio

5.46

3.35

7.1543

Slightly volatile

EV To Sales

5.48

5.77

8.0703

Pretty Stable

Inventory Turnover

2.15

2.7

2.7324

Pretty Stable

Days Of Inventory On Hand

174

140

135

Pretty Stable

Payables Turnover

3.75

6.47

5.8022

Pretty Stable

Sales General And Administrative To Revenue

0.0105

0.011

0.1528

Slightly volatile

Research And Ddevelopement To Revenue

0.33

0.35

0.2493

Slightly volatile

Capex To Revenue

0.0473

0.0498

0.0822

Pretty Stable

Cash Per Share

6.86

6.0

11.435

Pretty Stable

POCF Ratio

42.27

40.26

48.6

Slightly volatile

Capex To Operating Cash Flow

0.39

0.37

0.5848

Pretty Stable

Days Payables Outstanding

39.9

45.73

60.2204

Slightly volatile

EV To Operating Cash Flow

44.67

42.54

50.6691

Slightly volatile

Intangibles To Total Assets

0.52

0.49

0.382

Slightly volatile

Current Ratio

1.82

1.91

2.8143

Slightly volatile

Tangible Book Value Per Share

1.12

1.18

4.5663

Pretty Stable

Receivables Turnover

4.18

5.39

6.1183

Pretty Stable

Shareholders Equity Per Share

34.36

32.72

26.8695

Slightly volatile

Debt To Equity

0.35

0.3937

0.5389

Slightly volatile

Capex Per Share

0.69

1.11

1.746

Pretty Stable

Average Receivables

67.7 M

131 M

130.7 M

Pretty Stable

Revenue Per Share

26.94

25.66

21.4516

Slightly volatile

Interest Debt Per Share

13.99

13.32

14.0532

Slightly volatile

Debt To Assets

0.18

0.2

0.2801

Slightly volatile

Graham Number

26.29

51.76

49.5708

Slightly volatile

Short Term Coverage Ratios

4.75

5.0

42.9342

Very volatile

Operating Cycle

256

210

196

Pretty Stable

Price Book Value Ratio

5.46

3.35

7.1543

Slightly volatile

Days Of Payables Outstanding

39.9

45.73

60.2204

Slightly volatile

Price To Operating Cash Flows Ratio

42.27

40.26

48.6

Slightly volatile

Ebt Per Ebit

0.7

1.2

1.0381

Very volatile

Company Equity Multiplier

1.38

1.58

1.8613

Slightly volatile

Long Term Debt To Capitalization

0.19

0.2058

0.264

Slightly volatile

Total Debt To Capitalization

0.22

0.25

0.3424

Slightly volatile

Debt Equity Ratio

0.35

0.3937

0.5389

Slightly volatile

Quick Ratio

1.41

1.48

2.4659

Slightly volatile

Dividend Paid And Capex Coverage Ratio

2.32

2.21

2.5552

Slightly volatile

Net Income Per E B T

0.66

0.94

0.8662

Slightly volatile

Cash Ratio

0.73

0.77

1.0101

Slightly volatile

Cash Conversion Cycle

191

152

133

Pretty Stable

Operating Cash Flow Sales Ratio

0.1

0.0955

0.1943

Slightly volatile

Days Of Inventory Outstanding

174

140

135

Pretty Stable

Days Of Sales Outstanding

88.87

70.08

60.7877

Slightly volatile

Cash Flow Coverage Ratios

0.2

0.19

0.3337

Slightly volatile

Price To Book Ratio

5.46

3.35

7.1543

Slightly volatile

Fixed Asset Turnover

3.33

2.61

4.1362

Slightly volatile

Capital Expenditure Coverage Ratio

2.32

2.21

2.5552

Slightly volatile

Price Cash Flow Ratio

42.27

40.26

48.6

Slightly volatile

Debt Ratio

0.18

0.2

0.2801

Slightly volatile

Cash Flow To Debt Ratio

0.2

0.19

0.3337

Slightly volatile

Price Sales Ratio

5.19

5.46

7.7969

Pretty Stable

Asset Turnover

0.34

0.4

0.4486

Slightly volatile

Gross Profit Margin

0.79

0.7

0.6732

Pretty Stable

Price Fair Value

5.46

3.35

7.1543

Slightly volatile

Illumina Valuation Data

Trends

Current Value

Last Year

Historical Average

10 Year Trend

Market Cap

1.6 B

1.5 B

1.6 B

Slightly volatile

Enterprise Value

1.6 B

1.5 B

Slightly volatile

Illumina Fundamental Market Drivers

	Forward Price Earnings	26.9542
	Cash And Short Term Investments	1.2 B

Illumina Upcoming Events

	8th of February 2024 Upcoming Quarterly Report	View
	23rd of April 2024 Next Financial Report	View
	31st of December 2023 Next Fiscal Quarter End	View
	8th of February 2024 Next Fiscal Year End	View
	30th of September 2023 Last Quarter Report	View
	31st of December 2022 Last Financial Announcement	View

About Illumina Financial Statements

Illumina investors utilize fundamental indicators, such as revenue or net income, to predict how Illumina Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Current Deferred Revenue	260 M	273 M
Total Revenue	4.4 B	4.6 B
Cost Of Revenue	1.5 B	1.6 B
Stock Based Compensation To Revenue	0.10	0.09
Sales General And Administrative To Revenue	0.01	0.01
Research And Ddevelopement To Revenue	0.35	0.33
Capex To Revenue	0.05	0.05
Revenue Per Share	25.66	26.94
Ebit Per Revenue	(0.21)	(0.22)

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving against Illumina Stock

0.95	OSL	Oncosil Medical	Pair Corr
0.84	OBD	Oxford Biodynamics PLC	Pair Corr
0.82	603259	WuXi AppTec	Pair Corr
0.82	CDT	Conduit Pharmaceuticals	Pair Corr
0.77	TEM	Tempus AI, Class	Pair Corr

The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.

The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:

How To Invest In Illumina

Details

Is Illumina Stock a good investment?

Details

What is Illumina's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Illumina Correlation against competitors.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.78)

Earnings Share

4.45

Revenue Per Share

27.356

Quarterly Revenue Growth

0.004

Return On Assets

0.0915

The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC

Illumina Financial Statements From 2010 to 2025

Illumina Total Revenue

4.59 Billion

Illumina Balance Sheet

Illumina Income Statement

Illumina Cash Flow Statement

Financial Ratios

Illumina Valuation Data

Illumina Fundamental Market Drivers

Illumina Upcoming Events

About Illumina Financial Statements

Pair Trading with Illumina

Moving against Illumina Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY